YM-53601,182959-33-7

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

YM-53601

CAS No. : 182959-33-7

MCE 国际站：YM-53601

产品活性：YM-53601 是一种角鲨烯合酶 (squalene synthase) 抑制剂，可降低体内血浆胆固醇和甘油三酯水平。YM-53601 抑制源自人肝癌细胞的角鲨烯合酶，IC₅₀ 为 79 nM。可用作降脂剂。YM-53601 还是法呢基二磷酸法呢基转移酶 1 (FDFT1) 酶活性的抑制剂，可抑制 HCV 传播。

研究领域：Metabolic Enzyme/Protease  |  Anti-infection

作用靶点：Farnesyl Transferase  |  HCV

In Vitro: YM-53601 inhibits squalene synthase activities in hepatic microsomes from several species of rat, hamster, guinea-pig, rhesus monkey, and human-derived HepG2 cell with IC₅₀s of 90, 170, 46, 45, and 79 nM, respectively.
YM-53601 inhibits conversion of [3H]farnesyl diphosphate to [³H]squalene by hamster liver squalene synthase with the IC₅₀?of 170 nM.
YM-53601 (1 μM) potentiates the susceptibility of H35 cells to thapsigargin, lonidamine, and doxorubicin. YM-53601 (1 μM) reduces the mitochondrial cholesterol levels in both H35 and HepG2 cells.

In Vivo: YM-53601 suppresses cholesterol biosynthesis in rats (ED₅₀, 32?mg/kg).
YM-53601 also reduces plasma non-HDL cholesterol levels in hamsters by approximately 70% at an oral dose of 50 mg/kg/day for 5 days.
YM-53601 potentiates Doxorubicin-mediated hepatocellular carcinoma cells (HCC) growth arrest and cell death in vivo.

相关产品：Bioactive Compound Library Plus  |  Resiquimod  |  Honokiol  |  Ribavirin  |  Deferiprone  |  U18666A  |  AG-1478  |  Artemisinin  |  EIDD-1931  |  Tipifarnib  |  Asunaprevir  |  Myriocin  |  Grazoprevir  |  Simeprevir  |  NIM811  |  Sofosbuvir  |  Lonafarnib  |  RO8191  |  Vesatolimod  |  GS-443902 trisodium  |  L-778123 hydrochloride  |  Glecaprevir  |  BLT-1  |  Mizoribine  |  Daclatasvir  |  Ledipasvir  |  FTI-277 hydrochloride  |  Alisporivir  |  Boceprevir  |  Cyclo(Phe-Pro)  |  Azvudine hydrochloride

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds